GlaxoSmithKline Pharma to launch more vaccines in India
Drug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
By PTI |
MUMBAI: Drug major GlaxoSmithKline Pharmaceuticals on MOnday said it would be launching more vaccines in the Indian market.
"By the end of this year, we will launch three or four vaccines in the Indian market and a couple of drugs," GlaxoSmithKline MD Hasit B Joshipura told shareholders here.
The pharma firm would be launching vaccines for rotavirus diarrhoea, cervical cancer and pneumococcal diseases.
Since January, GlaxoSmithKline has launched two vaccines - pentavalent vaccine for infants and booster for enhanced immunity.
Estimates show that cervical cancer is one of the largest causes of cancer deaths among Indian women. And about 50,000 people die because of Rotaviral diarrhoea.
The vaccines form about Rs 120 crore of the business in India for GlaxoSmithKline Pharmaceuticals.
The company would be looking at the cosmeceutical segment, too. "We are actively looking for in-licencing deals in the cosmeceutical segment," he said.
"By the end of this year, we will launch three or four vaccines in the Indian market and a couple of drugs," GlaxoSmithKline MD Hasit B Joshipura told shareholders here.
The pharma firm would be launching vaccines for rotavirus diarrhoea, cervical cancer and pneumococcal diseases.
Since January, GlaxoSmithKline has launched two vaccines - pentavalent vaccine for infants and booster for enhanced immunity.
Estimates show that cervical cancer is one of the largest causes of cancer deaths among Indian women. And about 50,000 people die because of Rotaviral diarrhoea.
The vaccines form about Rs 120 crore of the business in India for GlaxoSmithKline Pharmaceuticals.
ADVERTISEMENT
The company would be looking at the cosmeceutical segment, too. "We are actively looking for in-licencing deals in the cosmeceutical segment," he said.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
